Table 2.
Metrics | Partial Correlation Coefficients (P Value) | ||||
---|---|---|---|---|---|
Duration | PANSS Positive | PANSS Negative | PANSS General | PANSS Overall | |
−0.287 (0.320) | 0.603 (0.023) | −0.204 (0.484) | 0.620 (0.018) | 0.407 (0.149) | |
−0.206 (0.479) | −0.126 (0.668) | −0.705 (0.004) | −0.371 (0.191) | −0.678 (0.007) | |
−0.099 (0.736) | 0.454 (0.103) | −0.581 (0.029) | 0.110 (0.708) | −0.141 (0.630) | |
−0.013 (0.965) | 0.330 (0.249) | −0.532 (0.047) | 0.192 (0.510) | −0.116 (0.692) | |
−0.287 (0.320) | 0.444 (0.111) | −0.642 (0.013) | −0.059 (0.842) | −0.267 (0.357) | |
−0.397 (0.160) | 0.426 (0.129) | −0.802 (<0.001)* | −0.107 (0.716) | −0.400 (0.157) | |
−0.256 (0.377) | −0.034 (0.907) | −0.711 (0.004)* | −0.200 (0.494) | −0.562 (0.036) |
Note: PANSS, Positive and Negative Symptom Scale; *Indicates correlation survived FDR (false discovery rate) threshold at q < 0.05. The partial correlation coefficients were estimated via multiple linear regressions with age, gender, age-by-gender interaction, and medication dosage as covariates. Significant correlation (P < 0.05) was indicated by the bold text. For the abbreviations of the cortical regions, see supplementary table 1.